Wolfgang Baiker was appointed CEO of Adrenomed AG by the company's Supervisory Board. Based in Berlin, Germany.
Dr. Wolfgang Baiker was appointed CEO of Adrenomed AG by the company's Supervisory Board. Adrenomed is a German, privately financed, clinical-stage biopharmaceutical company focused on treating sepsis and septic shock. Baiker leads the management team developing the lead product candidate Adrecizumab (INN: enibarcimab).
Full founder directory · Investor directory · Company funding database · Fundraising library